文献速递类风湿关节炎其他结缔组织病

台湾类风湿关节炎合并间质性肺病患者死亡危险因素分析:一项全国性人群队列研究

Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan.
PubMed 文献 · RMD Open · 2022-01-01

基于台湾1997至2013年全民健康保险研究数据库,纳入32289例新发类风湿关节炎(RA)患者,其中214例后续发生间质性肺病(ILD)。匹配分析显示ILD与RA患者死亡风险相关,RA-ILD患者中年龄、慢性阻塞性肺疾病、伴终末器官损害的糖尿病及泼尼松龙日剂量与死亡相关。

要点

  • 在倾向评分匹配人群中,ILD与RA患者死亡风险相关(HR 4.38,95%CI 2.03至9.43)。
  • RA-ILD患者中,年龄(aHR 1.04)、COPD(aHR 2.12)、伴终末器官损害的糖尿病(aHR 2.12)及泼尼松龙日剂量(aHR 1.09)与死亡相关。
  • 匹配前人群中ILD与死亡相关(aHR 1.73,95%CI 1.19至2.52)。

核心结论

  • 这项基于人群的队列研究显示,ILD与RA患者死亡风险相关,RA-ILD患者死亡相关因素包括年龄、COPD、伴终末器官损害的糖尿病及平均每日泼尼松龙剂量。

研究设计与样本

  • 使用1997至2013年台湾全民健康保险研究数据库,以国际疾病分类第九版编码识别2001至2013年32289例新发RA患者,其中214例后续发生ILD。
  • 按性别、年龄、ILD诊断时间和疾病病程以1:10匹配RA-ILD与对照,并对所选合并症进行倾向评分匹配(1:1)选择RA-ILD患者和对照。
  • 采用Cox比例风险模型估计两个匹配人群中ILD与死亡的相关性,并评估214例RA-ILD患者中与死亡相关的因素,以调整后HR(aHR)及95%CI表示。

主要发现

  • 倾向评分匹配前纳入164例RA-ILD患者和1640例对照,匹配后纳入155例RA-ILD患者和155例对照。
  • 匹配前人群中ILD与死亡相关(aHR 1.73;95%CI 1.19至2.52),倾向评分匹配人群中ILD与死亡相关(HR 4.38;95%CI 2.03至9.43)。
  • 214例RA-ILD患者中,年龄(aHR 1.04;95%CI 1.03至1.08)、COPD(aHR 2.12;95%CI 1.25至3.58)、伴终末器官损害的糖尿病(aHR 2.12;95%CI 1.25至3.58)及皮质类固醇剂量(泼尼松龙等效,mg/日)(aHR 1.09;95%CI 1.07至1.11)与死亡相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the risk and risk factors of mortality in patients with rheumatoid arthritis (RA) with interstitial lung disease (ILD). METHODS: Using the 1997-2013 Taiwanese National Health Insurance Research Database, we identified 32 289 incident patients with RA by using International Classification of Diseases, Ninth Revision codes from 2001 to 2013, and 214 patients developed ILD subsequently. We matched (1:10) RA-ILD with controls for sex, age, time of ILD diagnosis and disease duration. In addition, we conducted propensity score matching (PSM) (1:1) for selected comorbidities to choose RA-ILD patients and controls. Using the Cox proportional hazard model, we estimated the association of mortality with ILD for the two matched populations and assessed factors associated with mortality among 214 RA-ILD patients, shown as adjusted HRs (aHRs) with 95% CIs. RESULTS: In the populations selected before and after PSM, we included 164 and 155 patients with RA-ILD and 1640 and 155 controls, respectively. ILD was associated with mortality in the population before PSM (aHR, 1.73; 95% CI 1.19 to 2.52) and in the PSM population (HR 4.38; 95% CI 2.03 to 9.43). Among 214 patients with RA-ILD, age (aHR 1.04; 95% CI 1.03 to 1.08), chronic obstructive pulmonary disease (COPD) (aHR 2.12; 95% CI 1.25 to 3.58), diabetes mellitus (DM) with end-organ damage and corticosteroid dose (prednisolone equivalent, mg/day) (aHR 1.09; 95% CI 1.07 to 1.11) were associated with mortality in RA-ILD. CONCLUSION: This population-based cohort study showed that ILD was associated with risk of mortality in patients with RA, and risk factors associated with mortality in patients with RA-ILD included age, COPD, DM with end-organ damage and average daily prednisolone dose.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Ng KH, Chen DY, Lin CH, et al. Analysis of risk factors of mortality in rheumatoid arthritis patients with interstitial lung disease: a nationwide, population-based cohort study in Taiwan. RMD Open. 2022. PMID: 35995491. doi:10.1136/rmdopen-2022-002343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。